InvestorsHub Logo
Followers 1066
Posts 135767
Boards Moderated 0
Alias Born 08/25/2010

Re: None

Friday, 04/30/2021 10:33:57 AM

Friday, April 30, 2021 10:33:57 AM

Post# of 956
$OTLC FDA Granted Pediatric Disease Designation for OXi-4503

Treatment of Leukemia (AML)

@AstraZeneca reportedly paid $95 million to buy a priority review voucher from Orphan Biovitrum

@BiohavenPharma paid $105 million for a priority review voucher in March 2019

Everything I say is in my opinion, do your own DD and make your decision wisely! Don't spend more then you can afford to lose!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OTLC News